Obesity and Subtypes of Incident Cardiovascular Disease

Chiadi E Ndumele1, Kunihiro Matsushita2, Mariana Lazo3

  • 1Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD cndumel2@jhmi.edu.

Insights

Obesity significantly increases heart failure (HF) risk more than coronary heart disease or stroke. This link to HF remains unexplained by traditional risk factors, highlighting the need for weight management in HF prevention.

Area of Science:

  • Cardiology
  • Public Health
  • Obesity Research

Background:

  • Obesity is a known risk factor for cardiovascular disease (CVD) subtypes like coronary heart disease (CHD), heart failure (HF), and stroke.
  • Limited research exists comparing obesity's association with these CVD subtypes, especially concerning unexplained risk.
  • Understanding these differential associations is crucial for targeted CVD prevention strategies.

Purpose of the Study:

  • To compare the associations of higher body mass index (BMI) with incident HF, CHD, and stroke.
  • To determine the extent to which these associations are explained by traditional CVD risk factors.
  • To identify unique pathways linking obesity to specific CVD subtypes.

Main Methods:

  • Analysis of 13,730 participants from the Atherosclerosis Risk in Communities (ARIC) study with BMI ≥18.5 and no baseline CVD.
  • Follow-up for a median of 23 years to record incident HF, CHD, and stroke events.
  • Comparison of hazard ratios for severe obesity (BMI ≥35) across CVD subtypes before and after adjusting for demographics, lifestyle factors, and traditional CVD mediators.

Main Results:

  • Higher BMI showed the strongest association with incident HF compared to CHD and stroke.
  • Severe obesity (BMI ≥35) hazard ratios were 3.74 for HF, 2.00 for CHD, and 1.75 for stroke.
  • Adjusting for traditional mediators fully explained the BMI-CVD link for CHD and stroke, but not for HF.

Conclusions:

  • The association between obesity and HF is stronger than for other CVD subtypes and is not fully explained by traditional risk factors.
  • Weight management is critical for preventing heart failure.
  • Further research is needed to elucidate non-traditional pathways linking obesity to HF.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
330
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
351
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
532